Skip to main content Help with accessibility Skip to main navigation

Position Statements

BwD
Adopted
BP
Adopted
CSR
Adopted
EL
Adopted
FW
Adopted
GP
Adopted
MB
Adopted
WL
Pending

Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia

Date Posted: 20 - January - 2022
BNF chapter: Cardiovascular system

Please refer to the LSCMMG inclisiran medicines entry for further information on use within Lancashire and South Cumbria - RAG rated 'Green (Restricted)'.


Supporting Documents:

Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD